Maravai LifeSciences (MRVI) GC has 31,902 shares withheld for taxes

Rhea-AI Filing Summary

Maravai LifeSciences Holdings, Inc. reported a routine insider tax-withholding transaction by its General Counsel, Kurt Oreshack. On 01/15/2026, 31,902 shares of Class A common stock were withheld at a price of $3.69 per share to cover tax obligations triggered by the vesting of restricted stock units held by the insider. After this withholding, Oreshack beneficially owned 424,967 shares of Class A common stock directly. The transaction reflects share withholding for taxes rather than an open-market sale.

Insider Trade Summary

Net Seller: 31,902 shares

Net Sell 1 txn

Insider ORESHACK KURT

Role General Counsel

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Class A Common Stock	31,902	$3.69	$118K

Holdings After Transaction: Class A Common Stock — 424,967 shares (Direct)

Footnotes (1)

1. F1. Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 01/20/2026 - 05:28 PM Learn about SEC filing dates

FAQ

What insider transaction did MRVI report for Kurt Oreshack on January 15, 2026?

Maravai LifeSciences Holdings, Inc. reported that General Counsel Kurt Oreshack had 31,902 shares of Class A common stock withheld on 01/15/2026 to satisfy tax withholding obligations related to vesting restricted stock units.

Was the MRVI insider transaction an open-market sale of shares?

No. The filing states that the 31,902 shares "represent shares withheld to satisfy tax withholding obligations" in connection with vesting restricted stock unit awards, meaning the shares were not sold in an open-market transaction.

How many MRVI shares does Kurt Oreshack own after this transaction?

Following the reported tax-withholding transaction, General Counsel Kurt Oreshack beneficially owned 424,967 shares of Maravai LifeSciences Holdings, Inc. Class A common stock directly.

What does transaction code "F" mean in the MRVI Form 4 filing?

Transaction code "F" in this context indicates shares were withheld by the issuer to pay tax withholding obligations upon the vesting of equity awards, rather than a discretionary purchase or sale in the market.

What is Kurt Oreshack’s role at Maravai LifeSciences Holdings, Inc.?

The reporting person, Kurt Oreshack, is an officer of Maravai LifeSciences Holdings, Inc., serving as General Counsel, according to the Form 4.

How is the price per share reported in the MRVI insider tax-withholding transaction?

The withheld shares are reported at a price of $3.69 per share, which is used to calculate the value of the 31,902 shares applied toward tax withholding on vested restricted stock units.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ORESHACK KURT

(Last) (First) (Middle)

C/O MARAVAI LIFESCIENCES HOLDINGS, INC.

10770 WATERIDGE CIRCLE, SUITE 200

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MARAVAI LIFESCIENCES HOLDINGS, INC. [ MRVI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	01/15/2026		F		31,902(1)	D	$3.69	424,967	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.

Remarks:

	/s/ Kurt Oreshack	01/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.